QA: Abbott Laboratories in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2022_Abbott_Laboratories.pdf

Logs

Graph

Absolute values for 0000001800, Abbott Laboratories

  xvar xval
0 AssetsCurrent 24,239,000,000
1 IntangibleAssetsNetIncludingGoodwill 35,970,000,000
2 PropertyPlantAndEquipmentNet 8,959,000,000
3 remainder_Assets 6,028,000,000
4 LiabilitiesCurrent 13,105,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 18,861,463,627
8 SellingGeneralAndAdministrativeExpense 11,813,623,422
9 ResearchAndDevelopmentExpense 2,834,487,464
10 remainder_Expenses 3,662,455,694
11 remainder_Revenues 44,695,642,432
12 remainder_NetIncome 259,132,379
13 remainder_ComprehensiveNetIncome 276,150,721
  yvar yval
0 Assets 75,196,000,000
1 Liabilities 13,105,000,000
2 Expenses 37,172,030,207
3 Revenues 44,695,642,432
4 StockholdersEquity 62,091,000,000
5 NetIncome 7,782,744,604
6 ComprehensiveNetIncome 7,920,819,964
7 BaseVar 85,351,977,870
8 EconomicCapitalRatiobeforeLimitedLiability 3.25
9 EconomicCapitalRatio 3.85

Edgar->Model Mapping

Feature Distribution

Change over Time